{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:25:07Z","timestamp":1784589907575,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ijid.2022.02.002","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T10:34:00Z","timestamp":1644057240000},"page":"179-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Automated Susceptibility Testing With Vitek 2 Compared to MicroScan Reduces Vancomycin Alternative Therapy For Methicillin-Resistant Staphylococcus Aureus Bacteremia"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1710-336X","authenticated-orcid":false,"given":"Dusten T.","family":"Rose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Moskhos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Wibisono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly R.","family":"Reveles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.ijid.2022.02.002_bib0001","doi-asserted-by":"crossref","first-page":"S511","DOI":"10.1093\/ofid\/ofy210.1460","article-title":"Impact of susceptibility testing method on antibiotic selection for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia","volume":"5","author":"Bhatt","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2022.02.002_bib0002","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1093\/cid\/ciz1076","article-title":"Discharge delays and costs associated with outpatient parenteral antimicrobial therapy for high priced antibiotics","volume":"71","author":"Bianchini","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2022.02.002_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-12-40","article-title":"Classification of healthcare-associated infection: systematic review 10 years after the first proposal","volume":"12","author":"Cardoso","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.ijid.2022.02.002_bib0004","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1128\/AAC.00227-16","article-title":"Daptomycin improves outcomes regardless of vancomycin MIC in a propensity-matched analysis of methicillin-resistant Staphylococcus aureus bloodstream infection","volume":"60","author":"Claeys","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2022.02.002_bib0005","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2018"},{"key":"10.1016\/j.ijid.2022.02.002_bib0006","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","article-title":"Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2022.02.002_bib0007","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/ofid\/ofy270","article-title":"Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program","volume":"6","author":"Diekema","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2022.02.002_bib0008","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jinf.2016.12.007","article-title":"Determining vancomycin etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobials","volume":"74","author":"Hos","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2022.02.002_bib0009","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/cid\/cis469","article-title":"Should laboratories test methicillin-resistant Staphylococcus aureus for elevated vancomycin minimum inhibitory concentrations by Etest as a driver of treatment changes?","volume":"55","author":"Humphries","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2022.02.002_bib0010","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1001\/jama.2014.6364","article-title":"Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis","volume":"312","author":"Kalil","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2022.02.002_bib0011","doi-asserted-by":"crossref","first-page":"e01656","DOI":"10.1128\/AAC.01656-19","article-title":"A Prospective Cohort Study of Durations of Staphylococcus aureus Bacteremia According to Different Phenotypes and a New Concept of Persistent Bacteremia","volume":"64","author":"Kang","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2022.02.002_bib0012","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1017\/ice.2019.293","article-title":"Nudging in microbiology laboratory evaluation (NIMBLE): A scoping review","volume":"40","author":"Langford","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijid.2022.02.002_bib0013","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.diagmicrobio.2005.02.007","article-title":"Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia","volume":"52","author":"Lodise","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2022.02.002_bib0014","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2022.02.002_bib0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clinthera.2015.09.017","article-title":"Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg\/L: A Multicenter Evaluation","volume":"38","author":"Moise","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijid.2022.02.002_bib0016","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cid\/cir764","article-title":"Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study","volume":"54","author":"Moore","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2022.02.002_bib0017","doi-asserted-by":"crossref","first-page":"e00302","DOI":"10.1128\/AAC.00302-20","article-title":"Charnot-Katsikas A. From Etest to Vitek 2: Impact of Enterococcal linezolid susceptibility testing methodology on time to active therapy","volume":"64","author":"Nguyen","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2022.02.002_bib0018","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1128\/JCM.00448-13","article-title":"Evaluation of vancomycin susceptibility testing for methicillin-resistant Staphylococcus aureus: comparison of Etest and three automated testing methods","volume":"51","author":"Rybak","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2022.02.002_bib0019","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1097\/01.CCM.0000239121.09533.09","article-title":"Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database","volume":"34","author":"Shorr","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijid.2022.02.002_bib0020","doi-asserted-by":"crossref","first-page":"e01845","DOI":"10.1128\/AAC.01845-16","article-title":"Impact of Vancomycin MIC on Treatment Outcomes in Invasive Staphylococcus aureus infections","volume":"61","author":"Song","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2022.02.002_bib0021","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis","volume":"54","author":"van Hal","year":"2012","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222000819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222000819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:06:52Z","timestamp":1761120412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971222000819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":21,"alternative-id":["S1201971222000819"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2022.02.002","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automated Susceptibility Testing With Vitek 2 Compared to MicroScan Reduces Vancomycin Alternative Therapy For Methicillin-Resistant Staphylococcus Aureus Bacteremia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2022.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}